
Stellest achieves FDA-approval milestone
Breaking new ground, EssilorLuxottica’s Stellest lens is the first-ever spectacle lens clinically proven to slow myopia progression in children to receive the US Food and Drug Administration’s (FDA’s) market authorisation.












